Stony Brook University Hospital’s latest achievement in medical advancement—the implementation of Glean Urodynamics—is the first of its kind performed on the East Coast.
The wireless, catheter-free bladder monitoring system demonstrates progress in real time. Without the catheters, patient comfort is optimized like never before. Moreover, diagnostic precision is imminent with unprecedented access to such immediate results.
Thus, trial findings of Stony Brook’s new FDA-approved bladder monitoring system, as deployed within the hospital’s Women’s Pelvic Health and Continence Center, are to be published in the “Journal of Endourology.”
Dr. Jason Kim and Dr. Steven Weissbart performed one of the first procedures of its kind for the hospital. They used the ambulatory urodynamic system of California-based Bright Uro.
The aforementioned medical device company transforms care for lower urinary tract dysfunction.
According to Stony Brook University Hospital, nearly 17 million people nationwide experience daily bladder control issues; the “Glean System” approach is specially designed to evaluate the bladder function through more technologically enhanced measures.
The system utilizes a sensor deployed within the bladder. Reports suggest this method invites ambulatory monitoring of bladder pressure like no prior procedures.
Stony Brook University Hospital was just the second site in the nation to put this tech to use, per the Journal.
All in a day’s work, for those trained in what works, and tasked to find breakthrough solutions when all else fails.
“We are proud to be at the forefront of urologic innovation,” Dr. Kim said. “This new technology marks a major step forward in patient-centered care by providing a more physiologic, less invasive approach to urodynamic testing. This will improve both the quality of the data we gather and the patient experience overall.”